We have previously demonstrated that PRDX1 was increased in melanoma patients from the vertical growth phase compared to common nevus, and was decreased in metastatic melanoma compared to dysplastic nevus, whereas PRDX2 is decreased in the vertical growth phase and in melanoma metastasis when compared to dysplastic nevus [30]. The gene discussed is PRDX2; the disease is nevus.